Published in Diabetes on December 01, 1978
Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J (1986) 1.97
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age-related normal range. Br Med J (Clin Res Ed) (1982) 1.42
Impaired vagal heart rate control in coronary artery disease. Br Heart J (1987) 1.08
Autonomic neuropathy in acute intermittent porphyria. J Neurol Neurosurg Psychiatry (1985) 1.07
Cardiovascular autonomic neuropathy in HIV infected patients. Sex Transm Infect (1999) 1.00
Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry (1995) 0.98
Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J Clin Invest (1986) 0.96
Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 0.89
Cardiovascular reflexes in patients after myocardial infarction. Effect of long-term treatment with beta-adrenoceptor antagonists. Br Heart J (1980) 0.87
Nocturnal airflow obstruction, histamine, and the autonomic central nervous system in children with allergic asthma. Thorax (1991) 0.85
The heart in diabetes. West J Med (1984) 0.85
Analysis of heart rate variability as an index of noncardiac surgical stress. Heart Vessels (2008) 0.84
Aerobic training restores arterial baroreflex sensitivity in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Clin J Sport Med (2010) 0.84
The Valsalva manoeuvre as a cardiovascular reflex test in healthy children and teenagers. Clin Auton Res (1997) 0.81
Angiotensin II-NADPH oxidase-derived superoxide mediates diabetes-attenuated cell excitability of aortic baroreceptor neurons. Am J Physiol Cell Physiol (2011) 0.81
Elevated angiotensin II in rat nodose ganglia primes diabetes-blunted arterial baroreflex sensitivity: involvement of NADPH oxidase-derived superoxide. J Diabetes Metab (2011) 0.79
Effects of atropine on autonomic indices based on electrocardiographic R-R intervals in healthy volunteers. J Neurol Neurosurg Psychiatry (1992) 0.79
Acute angiotensin-converting enzyme inhibition evokes bradykinin-induced sympathetic activation in diabetic rats. Am J Physiol Regul Integr Comp Physiol (2007) 0.77
Effects of high ambient temperature on parasympathetically mediated cardiovascular reflexes in normal man. Br J Clin Pharmacol (2000) 0.77
Vasomotor responses to the Valsalva manoeuvre in normal subjects and in patients with diabetes mellitus. Br Heart J (1979) 0.75
Reduced sinus arrhythmia in diabetic autonomic neuropathy. Br Med J (Clin Res Ed) (1983) 0.75
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet (1988) 10.64
Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18
Insurance-related differences in the risk of ruptured appendix. N Engl J Med (1994) 6.69
The end of clinical freedom. Br Med J (Clin Res Ed) (1983) 6.27
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12
Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet (1988) 4.07
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet (1993) 3.43
Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17
Access to prenatal care following major Medicaid eligibility expansions. JAMA (1993) 3.04
Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93
Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation (2000) 2.90
Open access. BMJ (1995) 2.76
Comparison of results from a cardiac ambulance manned by medical or non-medical personnel. Lancet (1977) 2.75
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet (1990) 2.70
Follow-up of emergency ambulance calls in Nottingham: implications for coronary ambulance servie. Br Med J (1975) 2.66
Differences in hospital resource allocation among sick newborns according to insurance coverage. JAMA (1991) 2.59
Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol (1990) 2.58
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53
Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J (1992) 2.46
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Randomised trial of a mobile coronary care unit for emergency calls. Br Med J (1978) 2.35
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32
Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) (1981) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Opioid users' attitudes towards and use of NHS clinics, general practitioners and private doctors. Br J Addict (1986) 2.18
Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11
Hypovitaminosis D and 'functional hypoparathyroidism'-the NoNoF (Nottingham Neck of Femur) study. Age Ageing (2001) 2.09
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Mode of referral to hospital of patients with heart attacks: relevance to home care and special ambulance services. Br Med J (1976) 2.04
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med (1996) 2.00
An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun (1996) 1.99
Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Advanced training for ambulance crews: implications from 403 consecutive patients with cardiac arrest managed by crews with simple training. Br Med J (Clin Res Ed) (1987) 1.92
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br J Pharmacol (1991) 1.90
Rehydration in the treatment of severe hypercalcaemia. Q J Med (1981) 1.87
Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation (1996) 1.86
Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) (1981) 1.86
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Diagnostic criteria for myocardial infarction. Br J Hosp Med (1981) 1.82
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int J Cardiol (1993) 1.80
Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol (1990) 1.80
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br J Pharmacol (1990) 1.77
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Simple training programme for ambulance personnel in the management of cardiac arrest in the community. Br Med J (Clin Res Ed) (1985) 1.74
Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats? Am J Physiol (1990) 1.74
Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol (1990) 1.72
Neurological presentation of bacterial endocarditis. Br Med J (1967) 1.70
Differences in drug treatment of chronic heart failure between European countries. Eur Heart J (1999) 1.63
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
Serial abuse in children who are shaken. Am J Dis Child (1990) 1.62
Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats. J Cardiovasc Pharmacol (1989) 1.61
The National Service Framework for coronary heart disease: the emperor's new clothes. J R Coll Physicians Lond (2000) 1.60
The effect of adrenaline upon cardiovascular and metabolic functions in man. Clin Sci (Lond) (1985) 1.58
An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Br J Pharmacol (1970) 1.57
Comparison of mortality of patients with heart attacks admitted to a coronary care unit and an ordinary medical ward. Br Med J (1977) 1.57
Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55
Distal forearm fracture history in an older community-dwelling population: the Nottingham Community Osteoporosis (NOCOS) study. Age Ageing (2001) 1.52
The health of the nation's research and development. BMJ (1993) 1.52
Propofol and fentanyl compared with midazolam and fentanyl during third molar surgery. J Oral Maxillofac Surg (1998) 1.51
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
Is macrosomia associated with poor glycaemic control in diabetic pregnancy? Diabet Med (1996) 1.48
Variations in the use of coronary arteriography in the UK: the RITA trial coronary arteriogram register. QJM (1995) 1.47
The adrenergic nervous system of the domestic fowl (Gallus domesticus [L.]). Z Zellforsch Mikrosk Anat (1970) 1.45
Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. Br Med J (1979) 1.41
Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats. Br J Pharmacol (1991) 1.40
Opposition to USDA inspections and the inclusion of rats, mice, and birds in the AWA. Contemp Top Lab Anim Sci (2001) 1.39
The limited potential of special ambulance services in the management of cardiac arrest. Br Heart J (1990) 1.39
Captopril therapy for heart failure. A placebo controlled study. Lancet (1982) 1.39
Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev (1992) 1.38
The use of gamma cameras to measure the disposition and fate of iodide in the rabbit [proceedings]. Br J Pharmacol (1978) 1.38
Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats. Clin Sci (Lond) (1985) 1.38
Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37
The Saccharomyces cerevisiae RAD9 checkpoint reduces the DNA damage-associated stimulation of directed translocations. Mol Cell Biol (1998) 1.36
The Schizosaccharomyces pombe cwg2+ gene codes for the beta subunit of a geranylgeranyltransferase type I required for beta-glucan synthesis. EMBO J (1993) 1.35
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. Bone (2003) 1.34
Cardiovascular control in diabetes mellitus. Br Med J (1975) 1.34
Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res (1967) 1.32
Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol (1988) 1.32
Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry (1976) 1.31
Abnormalities in platelet behaviour in acute illnesses. Br Med J (1966) 1.31
Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31
Comparison of the renal and skeletal actions of calcitonin in the treatment of severe hypercalcaemia of malignancy. Q J Med (1984) 1.30